Global Congress on Comparator Studies

This is a reminder that the Global Congress on Comparator Studies conference kicks off on Monday in Philadelphia. There is still time to register if you’re interested in integrating a comprehensive blueprint for your comparator studies. Get your comparator studies up to standards before the new administration mandates it.

A selection of confirmed attendees:
Allergan Inc * Almac Clinical Services * Bernstein CMC Regulatory Consulting * Celgene * Cerexa Inc * Eli Lilly & Co * Facet Biotech Corporation * Farma Mondo SA * GlaxoSmithKline * Hospira Inc * Human Genome Sciences Inc * Merck & Company Inc * Multipharma Inc * Mylan Pharmaceuticals Inc * Myoderm Medical * Pfizer * Schering Plough Corporation * Takeda Pharmaceuticals North America Inc * Wyeth Pharmaceuticals

Global Congress on Comparator Studies 2009 is offering a terrific three day conference to amalgamate with industry thought leaders, network with colleagues and develop relationships with industry professionals. Join us to hear insight into how industry leaders are minimizing operational, regulatory and financial risks.

Share this article with your social network, just click below to share now!

Share |

Green Pharma Summit: Who you're going to hear from

Who is going to be at this year's Green Pharma Summit?

Over 20 Leading Pharmaceutical and Industry sustainability experts providing you with green strategies and tools that you can implement immediately upon your return:

Pharma/Biotech
• Michael Whaley, Director of Environmental Health and Safety, Allergan
• Ann Lee-Jeffs, Manager, Worldwide Environmental Affairs, Johnson & Johnson
• Ingrid Mergelsberg, PhD, Director, Chemical and Physical Sciences (Chemical Development), Schering -Plough Research Institute
• Concepcion Jimenez-Gonzalez, PhD, Director, Operational Sustainability, GlaxoSmithKline
• Peter Dunn, PhD, Green Chemistry Team Leader, Pfizer
• Marcus Chung, MBA, Director, Corporate Citizenship, McKesson Corporation
• James Hagan, Vice President, Corporate Environment, Health, Safety and Sustainability, GlaxoSmithKline
• Norman Goldschmidt, Principal, Pharma Engineering Advisors, and Former Sr. Director of Global Engineering & Design, Bristol-Myers Squibb

Government
• Chen Wen, Office of Prevention, Pesticides and Toxics, US Environmental Protection Agency
• Åke Wennmalm, MD, PhD, Professor, Environmental Director, Stockholm County Council
• Michael Gonzalez, National Risk Management Research Lab, US Environmental Protection Agency
• Walt Tunnessen, National Program Director for the EPA Energy Star® Program, US Environmental Protection Agency

Academia
• Terrence J. Collins, PhD, Thomas Lord Professor of Chemistry, Director, Institute for Green Science, Carnegie Mellon University
• William Trombetta, Professor of Marketing, St. Joseph’s University

Enviromental Guru Keynote
• Kim Carlson, Founder, Earthsmart Consumer and author of Green Your Work: Boost Your Bottom Line While Reducing Your Carbon Footprint

The Green Pharma Summit is about how Pharma is going green. Pharmaceutical companies are discovering that going green is not just for altruistic reasons, but that going green actually has benefits to the bottom line. Going green saves and makes money. If you'd like to network with other professionals who are working in the Green Pharma field, join our Green Pharma LinkedIn Group!

Share this article with your social network, just click below to share now!

Share |

What are companies doing to make Pharma greener?

The pharmaceutical sector is working hard to adopt more sustainable and environmentally friendly practices that offer measurable improvements without sacrificing the bottom-line. As more and more environmental health and sustainability professionals turn their attention to green initiatives, the c-suite is looking to these programs to deliver measurable value with quantifiable impact.

At the Green Pharma Summit, learn how…
* Johnson & Johnson and GlaxoSmithKline adopted successful greening strategies to engage all departments
* Pfizer implemented a company-wide Green Chemistry Team to substantially reduce waste throughout their manufacturing and chemical development processes
* Allergan earned the US EPA Energy Star® Partner of the Year Award by implementing Green R&D and manufacturing practices for energy efficiencies and cost savings
* Schering-Plough influences smart solvent and reagent choices by implementing solvent selection guides to encourage Green decisions from the start

To network with other professionals in the Green Pharma field, we invite you to join our LinkedIn group here.

Share this article with your social network, just click below to share now!

Share |